Skip to main content
. 2022 Mar 14;45(5):1247–1251. doi: 10.2337/dc21-2434

Figure 2.

Figure 2

The 5mGS in the empagliflozin, metformin, and insulin groups measured at baseline and follow-up. Data are means ± SD. *P < 0.05, ***P < 0.001.